Amy B. Cadwallader

Amy B. Cadwallader, PhD, currently serves as the Director of Regulatory and Public Policy Development and Quality Institute at US Pharmacopeia, where responsibilities include leading the development of global regulatory policies and fostering relationships with government officials and stakeholders. Prior experience includes directing science and drug policy at the American Medical Association, where Amy managed multiple task forces and provided expertise on public health policies. Earlier roles also encompass senior scientific and policy positions across organizations such as Aegis Sciences Corporation and Laboratorio Antidoping FMSI, alongside academic contributions as an adjunct faculty member at John Cabot University. Amy holds a PhD in Pharmacology/Toxicology from the University of Utah and advanced degrees in Biology/Forensic Science and Chemistry.